Yoshihiro Maruo Selected Research

Neoplasms (Cancer)

4/2024	Challenges in the management of Turner syndrome with Y chromosome material: a case report of prophylactic gonadectomy revealing dysgerminoma.
1/2019	Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase δ syndrome type 1.
6/2016	Remitted epilepsy with dysembryoplastic neuroepithelial tumor involving the thalamus.
1/2016	Contribution of UGT1A1 variations to chemotherapy-induced unconjugated hyperbilirubinemia in pediatric leukemia patients.
8/2004	A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshihiro Maruo Research Topics

Disease

7	Gilbert Disease 02/2016 - 01/2002
6	Hyperbilirubinemia 11/2017 - 09/2004
5	Neoplasms (Cancer) 04/2024 - 08/2004
5	Crigler-Najjar Syndrome 02/2016 - 01/2002
3	Congenital Hypothyroidism (Cretinism) 05/2024 - 11/2008
3	Kernicterus 01/2021 - 12/2015
3	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2021 - 01/2019
3	Jaundice (Icterus) 07/2014 - 03/2011
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2024 - 01/2020
2	Intellectual Disability (Idiocy) 12/2023 - 01/2016
2	Ganglion Cysts (Ganglion) 08/2022 - 11/2020
2	Drug Resistant Epilepsy 06/2021 - 06/2016
2	Seizures (Absence Seizure) 06/2021 - 04/2010
2	Body Weight (Weight, Body) 01/2021 - 11/2011
2	Type 2 Diabetes Mellitus (MODY) 11/2019 - 02/2012
2	Primary Immunodeficiency Diseases 01/2019 - 12/2016
2	Hypothyroidism 04/2016 - 11/2008
2	type 2 Crigler Najjar syndrome 02/2016 - 03/2011
2	Carcinogenesis 12/2011 - 04/2005
2	Drug-Related Side Effects and Adverse Reactions 12/2011 - 04/2005
2	Hereditary Spherocytosis 03/2011 - 02/2009
2	Hemolysis 03/2011 - 02/2009
1	Lymphopenia (Lymphocytopenia) 04/2024
1	Nephritis 04/2024
1	Dysgerminoma 04/2024
1	Turner Syndrome (Turner's Syndrome) 04/2024
1	2 X-Linked Lymphoproliferative Syndrome 01/2024
1	Neurodevelopmental Disorders 12/2023
1	Chorioamnionitis 04/2023
1	Infections 04/2023
1	Diarrhea 03/2023
1	Neutropenia 03/2023
1	Neonatal Jaundice 01/2023
1	Lysinuric Protein Intolerance 10/2022
1	Pancreatitis 06/2021
1	Obesity 06/2021
1	Hypoglycemia (Reactive Hypoglycemia) 06/2021
1	Glucose Intolerance 06/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2021
1	Acute Necrotizing Pancreatitis 06/2021
1	Multiple Organ Failure (MODS) 06/2021
1	MEHMO syndrome 06/2021
1	Hereditary Hyperbilirubinemia (Rotor Syndrome) 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Weight Gain 01/2021
1	Iron Deficiencies 01/2020
1	Experimental Arthritis 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Cognitive Dysfunction 01/2020
1	Type 2 Maturity-Onset Diabetes of the Young 11/2019
1	Birth Weight (Birth Weights) 11/2019
1	Birth Injuries (Birth Injury) 11/2019
1	Mason-Type Diabetes 11/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019
1	Herpesviridae Infections (Herpesvirus Infection) 01/2019
1	Hyperplasia 01/2019
1	Hemorrhage 05/2018
1	Hypotension (Low Blood Pressure) 01/2018
1	Bradycardia 01/2018

Drug/Important Bio-Agent (IBA)

15	BilirubinIBA 01/2023 - 01/2002
8	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 03/2023 - 09/2004
5	Uridine Diphosphate (UDP)IBA 03/2023 - 09/2004
5	bilirubin glucuronoside glucuronosyltransferaseIBA 07/2014 - 11/2003
3	Insulin (Novolin)FDA Link 06/2021 - 02/2012
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2021
2	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2019
2	Histamine (Histamine Dihydrochloride)FDA Link 11/2020 - 04/2010
2	Intravenous Immunoglobulins (IVIG)FDA Link 11/2016 - 11/2011
2	SteroidsIBA 11/2016 - 09/2011
2	Dual OxidasesIBA 04/2016 - 11/2008
2	UGT1A1 enzymeIBA 11/2015 - 03/2011
2	DNA (Deoxyribonucleic Acid)IBA 07/2006 - 01/2003
1	Thyroid HormonesIBA 05/2024
1	moesinIBA 04/2024
1	X-Linked Inhibitor of Apoptosis ProteinIBA 01/2024
1	diazonaphthalenedisulfonic acid (NDS)IBA 12/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2023
1	Irinotecan (Camptosar)FDA LinkGeneric 03/2023
1	Amino Acids FDA Link 10/2022
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 08/2022
1	Nicotine FDA Link 08/2022
1	Glucose (Dextrose)FDA LinkGeneric 06/2021
1	Mydriatics (Cycloplegics)IBA 01/2021
1	CationsIBA 11/2020
1	AntibodiesIBA 01/2020
1	Fibrinogen (Factor I)FDA Link 01/2020
1	Collagen Type II (Type II Collagen)IBA 01/2020
1	GlucokinaseIBA 11/2019
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2019
1	HemosiderinIBA 05/2018

Therapy/Procedure

5	Therapeutics 01/2024 - 01/2016
2	Cell Transplantation 01/2024 - 11/2011
2	Drug Therapy (Chemotherapy) 01/2016 - 09/2011
2	Liver Transplantation 12/2015 - 07/2006
1	Castration 04/2024
1	Ketogenic Diet 06/2021
1	Critical Care (Surgical Intensive Care) 06/2021
1	Hematopoietic Stem Cell Transplantation 01/2019
1	Intravitreal Injections 01/2019
1	Intraocular Injections 01/2019